Nautilus Biotechnology, Inc. (NAUT)
2.25
+0.43
(+23.63%)
USD |
NASDAQ |
Oct 09, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Total Liabilities (Quarterly) : 32.46M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.46M |
| March 31, 2026 | 33.36M |
| December 31, 2025 | 34.14M |
| September 30, 2025 | 31.78M |
| June 30, 2025 | 32.10M |
| March 31, 2025 | 33.26M |
| December 31, 2024 | 34.01M |
| September 30, 2024 | 36.27M |
| June 30, 2024 | 37.47M |
| March 31, 2024 | 39.16M |
| December 31, 2023 | 40.21M |
| September 30, 2023 | 41.06M |
| June 30, 2023 | 41.09M |
| Date | Value |
|---|---|
| March 31, 2023 | 42.17M |
| December 31, 2022 | 35.13M |
| September 30, 2022 | 33.97M |
| June 30, 2022 | 34.15M |
| March 31, 2022 | 34.96M |
| December 31, 2021 | 34.87M |
| September 30, 2021 | 7.50M |
| June 30, 2021 | 3.231M |
| March 31, 2021 | 7.032M |
| December 31, 2020 | 114.73M |
| September 30, 2020 | 5.361M |
| June 30, 2020 | 0.198M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 6.604B |
| Bio-Rad Laboratories, Inc. | 3.078B |
| Bruker Corp. | 3.617B |
| Danaher Corp. | 39.78B |
| Harvard Bioscience, Inc. | 68.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 163.58M |
| Shareholders Equity (Quarterly) | 131.11M |
| Debt to Equity Ratio | 0.2122 |
| Current Ratio | 10.14 |
| Net Debt Paydown Yield | 0.13% |